Rizatriptan
NDC 33342-087, Rizatriptan, tablet, film coated, from Macleods Pharmaceuticals Limited.
- Product NDC
- 33342-087
- Status
- Listed
- Labeler
- Macleods Pharmaceuticals Limited
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203147
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/33342-087 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RIZATRIPTAN BENZOATE5 mg/1
Pharmacologic classes
Serotonin 1b Receptor Agonists [MoA]; Serotonin 1d Receptor Agonists [MoA]; Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 33342-087-07 | 33342008707 | 30 TABLET, FILM COATED in 1 CONTAINER (33342-087-07) |
| 33342-087-12 | 33342008712 | 10 BLISTER PACK in 1 CARTON (33342-087-12) / 10 TABLET, FILM COATED in 1 BLISTER PACK |
| 33342-087-41 | 33342008741 | 3 BLISTER PACK in 1 CARTON (33342-087-41) / 6 TABLET, FILM COATED in 1 BLISTER PACK (33342-087-02) |
| 33342-087-45 | 33342008745 | 2 BLISTER PACK in 1 CARTON (33342-087-45) / 6 TABLET, FILM COATED in 1 BLISTER PACK (33342-087-02) |
| 33342-087-46 | 33342008746 | 200 TABLET, FILM COATED in 1 CONTAINER (33342-087-46) |
| 33342-087-50 | 33342008750 | 4 BLISTER PACK in 1 CARTON (33342-087-50) / 3 TABLET, FILM COATED in 1 BLISTER PACK (33342-087-52) |
| 33342-087-72 | 33342008772 | 6 BLISTER PACK in 1 CARTON (33342-087-72) / 3 TABLET, FILM COATED in 1 BLISTER PACK (33342-087-52) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/27bc2cfc-fefb-4b50-a0dc-6268c69b4902NADAC price for package 33342008741
GET /v1/drugs/nadac/33342008741NADAC price for package 33342008745
GET /v1/drugs/nadac/33342008745
Use it
Look up 33342-087 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/33342-087 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 33342-087. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.